Morgan Stanley Olema Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,437,407 shares of OLMA stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,437,407

Previous 451,691 218.23%

Holding current value

$10.7 Million

Previous $1.7 Million 260.6%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$3.06 - $5.62 $3.02 Million - $5.54 Million	985,716 Added 218.23%	1,437,407 $6.12 Million
Q1 2025 May 15, 2025	SELL	$3.76 - $6.39 $2.15 Million - $3.66 Million	-572,786 Reduced 55.91%	451,691 $1.7 Million
Q4 2024 Feb 14, 2025	BUY	$5.61 - $12.72 $4.35 Million - $9.86 Million	774,876 Added 310.45%	1,024,477 $5.97 Million
Q3 2024 May 14, 2025	SELL	$10.41 - $16.46 $894,947 - $1.42 Million	-85,970 Reduced 25.62%	249,601 $2.98 Million
Q3 2024 Nov 14, 2024	SELL	$10.41 - $16.46 $894,947 - $1.42 Million	-85,970 Reduced 25.62%	249,601 $2.98 Million
Q2 2024 May 14, 2025	SELL	$8.73 - $13.99 $6.01 Million - $9.64 Million	-688,906 Reduced 67.24%	335,571 $3.63 Million
Q2 2024 Oct 17, 2024	SELL	$8.73 - $13.99 $1.42 Million - $2.27 Million	-162,555 Reduced 32.63%	335,571 $3.63 Million
Q2 2024 Aug 14, 2024	SELL	$8.73 - $13.99 $1.42 Million - $2.27 Million	-162,555 Reduced 32.63%	335,571 $3.63 Million
Q1 2024 Oct 17, 2024	BUY	$10.95 - $16.62 $1.78 Million - $2.7 Million	162,555 Added 48.44%	498,126 $5.64 Million
Q1 2024 Aug 16, 2024	BUY	$10.95 - $16.62 $3,087 - $4,686	282 Added 0.06%	498,126 $5.64 Million
Q1 2024 May 15, 2024	BUY	$10.95 - $16.62 $3,087 - $4,686	282 Added 0.06%	498,126 $5.64 Million
Q4 2023 Aug 16, 2024	BUY	$10.53 - $17.14 $1.71 Million - $2.78 Million	162,273 Added 48.36%	497,844 $6.98 Million
Q4 2023 Feb 13, 2024	BUY	$10.53 - $17.14 $4.7 Million - $7.65 Million	446,318 Added 866.2%	497,844 $6.98 Million
Q3 2023 Nov 15, 2023	SELL	$8.19 - $12.98 $92,800 - $147,076	-11,331 Reduced 18.03%	51,526 $636,000
Q2 2023 Aug 14, 2023	SELL	$3.22 - $9.65 $164,326 - $492,468	-51,033 Reduced 44.81%	62,857 $567,000
Q1 2023 May 15, 2023	SELL	$2.55 - $4.97 $227,031 - $442,489	-89,032 Reduced 43.87%	113,890 $395,000
Q4 2022 Feb 14, 2023	SELL	$2.27 - $3.76 $192,001 - $318,028	-84,582 Reduced 29.42%	202,922 $497,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.88 $405,084 - $875,696	-148,928 Reduced 34.12%	287,504 $793,000
Q2 2022 Oct 27, 2022	SELL	$2.04 - $4.61 $344,409 - $778,297	-168,828 Reduced 27.89%	436,432 $1.78 Million
Q2 2022 Aug 15, 2022	SELL	$2.04 - $4.61 $344,409 - $778,297	-168,828 Reduced 27.89%	436,432 $1.78 Million
Q1 2022 Oct 27, 2022	BUY	$3.89 - $9.43 $656,740 - $1.59 Million	168,828 Added 38.68%	605,260 $2.58 Million
Q1 2022 May 13, 2022	BUY	$3.89 - $9.43 $50,317 - $121,977	12,935 Added 2.18%	605,260 $2.58 Million
Q4 2021 Feb 14, 2022	BUY	$8.75 - $30.71 $4.43 Million - $15.5 Million	506,201 Added 587.76%	592,325 $5.54 Million
Q3 2021 Nov 15, 2021	BUY	$22.96 - $30.13 $1.98 Million - $2.59 Million	86,124 New	86,124 $2.37 Million

Others Institutions Holding OLMA

# of Institutions

125

Shares Held

68.8M

Call Options Held

Put Options Held

31.4K

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $301M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account